Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Monovalent Pandemic H5N1 Vaccine in Adults
Clinical trial NCT01416571 · COMPLETED
Trial details
- NCT number
- NCT01416571
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-12
- Primary completion
- 2011-11-29
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.